Literature DB >> 2841766

Epstein-Barr virus and lymphoproliferative disorders.

J L Sullivan1.   

Abstract

Entities:  

Mesh：

Year:  1988        PMID： 2841766

Source DB:  PubMed          Journal:  Semin Hematol        ISSN： 0037-1963            Impact factor:   3.851


× No keyword cloud information.
  9 in total

1.  Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation.

Authors:  J I Cohen; F Wang; J Mannick; E Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

2.  The detection of Epstein-Barr virus in hairy cell leukemia cells by in situ hybridization.

Authors:  B C Wolf; A W Martin; R S Neiman; A J Janckila; L T Yam; A Caracansi; B A Leav; R Winpenny; D S Schultz; H J Wolfe
Journal:  Am J Pathol       Date:  1990-03       Impact factor: 4.307

Review 3.  X-linked lymphoproliferative disease (XLP) as a model of Epstein-Barr virus-induced immunopathology.

Authors:  D T Purtilo
Journal:  Springer Semin Immunopathol       Date:  1991

4.  Expression of c-myc and bcl-2 oncogene products in Reed-Sternberg cells independent of presence of Epstein-Barr virus.

Authors:  N M Jiwa; P Kanavaros; P van der Valk; J M Walboomers; A Horstman; W Vos; H Mullink; C J Meijer
Journal:  J Clin Pathol       Date:  1993-03       Impact factor: 3.411

5.  Expression of bcl-2 and p53 proteins in nasopharyngeal carcinoma. Absence of correlation with the presence of EBV encoded EBER1-2 transcripts and latent membrane protein-1.

Authors:  C Kouvidou; P Kanavaros; D Papaioannou; E Stathopoulos; F Sotsiou; G Datseris; M Tzardi; C Kittas; G Delides
Journal:  Clin Mol Pathol       Date:  1995-02

6.  AIDS-related lymphoma. Histopathology, immunophenotype, and association with Epstein-Barr virus as demonstrated by in situ nucleic acid hybridization.

Authors:  S J Hamilton-Dutoit; G Pallesen; M B Franzmann; J Karkov; F Black; P Skinhøj; C Pedersen
Journal:  Am J Pathol       Date:  1991-01       Impact factor: 4.307

7.  Activation of Epstein-Barr virus by saliva from Sjogren's syndrome patients.

Authors:  Yoshifumi Nagata; Hiroko Inoue; Koichi Yamada; Hiroyuki Higashiyama; Kenji Mishima; Yasuhiro Kizu; Ienaka Takeda; Fumio Mizuno; Yoshio Hayashi; Ichiro Saito
Journal:  Immunology       Date:  2004-02       Impact factor: 7.397

8.  Lymphotoxin is an autocrine growth factor for Epstein-Barr virus-infected B cell lines.

Authors:  Z Estrov; R Kurzrock; E Pocsik; S Pathak; H M Kantarjian; T F Zipf; D Harris; M Talpaz; B B Aggarwal
Journal:  J Exp Med       Date:  1993-03-01       Impact factor: 14.307

9.  Epstein-Barr virus-associated post-transplant non-Hodgkin's lymphoma: establishment and characterization of a new cell line.

Authors:  K Kawashima; K Hayashi; T Ohnoshi; N Teramoto; I Kimura
Journal:  Jpn J Cancer Res       Date:  1994-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.